Schonfeld Strategic Advisors LLC Gilead Sciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 590,491 shares of GILD stock, worth $55.2 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

590,491

Previous 777,940 24.1%

Holding current value

$55.2 Million

Previous $53.4 Million 7.27%

% of portfolio

0.36%

Previous 0.36%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $12.5 Million - $15.7 Million	-187,449 Reduced 24.1%	590,491 $49.5 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $32.8 Million - $37.9 Million	519,925 Added 201.51%	777,940 $53.4 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $9.17 Million - $11.2 Million	-128,102 Reduced 33.18%	258,015 $18.9 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $27.4 Million - $31.1 Million	374,156 Added 3128.13%	386,117 $31.3 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $884,396 - $964,893	11,961 New	11,961 $896,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $3.31 Million - $3.77 Million	-42,807 Reduced 57.03%	32,257 $2.68 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $2.86 Million - $4.1 Million	-45,828 Reduced 37.91%	75,064 $6.44 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $3.25 Million - $3.71 Million	-54,584 Reduced 31.11%	120,892 $7.46 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $3.03 Million - $3.42 Million	52,576 Added 42.78%	175,476 $10.8 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.68 Million - $2.1 Million	28,989 Added 30.87%	122,900 $7.31 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $5.69 Million - $6.46 Million	87,750 Added 1424.28%	93,911 $6.82 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $5.43 Million - $5.93 Million	-85,476 Reduced 93.28%	6,161 $424,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $3.66 Million - $4.17 Million	60,937 Added 198.49%	91,637 $5.92 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.01 Million - $1.15 Million	17,827 Added 138.48%	30,700 $1.79 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.26 Million - $1.59 Million	-20,324 Reduced 61.22%	12,873 $1,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $461,456 - $535,836	6,379 Added 23.79%	33,197 $2.55 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $9.24 Million - $11.8 Million	-147,530 Reduced 84.62%	26,818 $2.01 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $9.36 Million - $10.3 Million	151,848 Added 674.88%	174,348 $11.3 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.87 Million - $2.06 Million	-29,874 Reduced 57.04%	22,500 $1.43 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $3.54 Million - $3.97 Million	-57,235 Reduced 52.22%	52,374 $3.54 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.17 Million - $4.67 Million	66,703 Added 155.46%	109,609 $7.13 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.02 Million - $2.64 Million	33,406 Added 351.64%	42,906 $2.68 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $42,768 - $47,352	-600 Reduced 5.94%	9,500 $733,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $242,716 - $283,118	3,741 Added 58.83%	10,100 $716,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $463,189 - $564,679	6,359 New	6,359 $480,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Gilead Sciences, Inc. Transaction History